Search Results for: postbiotics

Postbiotics as a new frontier in healthcare: from gut barrier function to cancer immunotherapy

Giuseppe Penna, from Humanitas University (Italy), presents the development of a novel postbiotic obtained from a single bacterial strain through an innovative fermentation process.

Postbiotics: the story, the evidences, the ingredient

How postbiotics are reshaping dietary supplements and pharma: key insights from Humiome® Post LB.

Postbiotics and Biotic Vitamins: the new frontier of health

dsm-firmenich Italy successfully hosts its first exclusive event on biotics.

Postbiotics: how heat-treated Lactobacilli (postbiotic) can improve gut-friendly Bifidobacteria growth

Postbiotics can selectively enhance beneficial microbes, offering a safe and effective microbiome-support strategy.

IPC 2023 and the postbiotics session: the gathering of the different parties 

The highlights of the Postbiotics Discussion Panel that took place in Bratislava during IPC 2023.

Adare Pharma Solutions announces divestiture of postbiotics pioneer Adare Biome to dsm-firmenich

The transaction represents an enterprise value of €275 million, an estimated 2023 EV/EBITDA multiple of 18x.

Postbiotics, from bench to bedside

An open discussion about definition, clinical trial design and fields of application of postbiotics with Maria Rescigno, Professor at Humanitas University of Milan.

IPA expands scope to include prebiotics, postbiotics and synbiotics

The International Probiotics Association’s expansion is part of the organization’s strategy to help the ’biotics’ industry grow in response to market demands.

Defining postbiotics: ISAPP consensus to set record straight on what postbiotics are … and are not

A new study helps to explain how nerve cells sense the microbes in the gut and how they coordinate their function with other tissues in the digestive tract.

Ross Youngs: ‘We investigate the aquatic microbiome to obtain metabolites and postbiotics’

New technologies such as the analysis of the "aquatic microbiota" allow to dig deeply into the microbiome chemistry. We discuss this approach with Ross Youngs, CEO of Biosortia.

Subscribe to MicrobiomePost newsletter

Take full advantage of MicrobiomePost‘s features.